529 Million People Living With Diabetes Worldwide in 2021
More than 1.31 billion projected to have diabetes by 2050, with almost half of countries having age-standardized rate greater than 10%.
Diagnosis & Disease Information
Recent 2023 FDA Approvals
Recent FDA approvals include treatments for chronic migraine, type 1 diabetes, blood cancers, tardive dyskinesia and chorea associated with Huntington disease, vasomotor symptoms of menopause, pain and fever, and Fabry disease.
FDA Clears iLet Bionic Pancreas for Patients With Type 1 Diabetes
The iLet Bionic Pancreas uses an adaptive closed-loop algorithm requiring only a user’s body weight for start-up and no additional insulin dosing parameters.
Residential Segregation Tied to Worse Type 1 Diabetes Outcomes in Black Youth
Findings persist even after controlling for adverse neighborhood conditions.
More than 60% of Adults With Type 1 Diabetes Have Overweight, Obesity
Those with type 1 diabetes are least likely to increase physical activity, reduce caloric intake to manage overweight or obesity.
2023 Standards of Care in Diabetes Released
ADA’s Dr Gabbay discusses the top changes to the Standards of Care in Diabetes—2023
New Guideline on Diabetes-Related Hypoglycemia Management Released
Endocrine Society Clinical Practice Guideline examines better ways to manage hypoglycemia in people with diabetes.
Tzield Approved to Delay Onset of Stage 3 Type 1 Diabetes
Tzield is anti-CD3 monoclonal antibody that has been shown to preserve beta cell function, reducing the need for exogenous insulin.
Insulin Rationing Reported by 16.5 Percent of Insulin Users
Variation seen among subgroups, with rationing in 11.2% of those aged 65 years and older and 20.4% of younger persons.
Bionic Pancreas Bests Standard Care for Glycemic Control in Type 1 Diabetes
Researchers compare the reduction in glycated hemoglobin level with use of a bionic pancreas compared with standard care in children and adults with type 1 diabetes.
- Loading...
Loading...
Loading... 
Loading...